Autors:

CiteWeb id: 20020000126

CiteWeb score: 4541

DOI: 10.1016/S0140-6736(02)08512-4

We did a randomised controlled trial to assess the benefit of maintenance infliximab therapy in patients with active Crohn's disease who respond to a single infusion of infliximab.

Links: